未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial
Bengtsson, Anna; Norberg, Margareta; Ng, Nawi; Carlberg, Bo; Gronlund, Christer; Hultdin, Johan; Lindahl, Bernt; Lindahl, Bertil; Nordin, Steven; Nyman, Emma; Wennberg, Patrik; Wester, Per; Naslund, Ulf
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial
Naslund, Ulf; Ng, Nawi; Lundgren, Anna; Fharm, Eva; Gronlund, Christer; Johansson, Helene; Lindahl, Bernt; Lindahl, Bertil; Lindvall, Kristina; Nilsson, Stefan K.; Nordin, Maria; Nordin, Steven; Nyman, Emma; Rocklov, Joacim; Vanoli, Davide; Weinehall, Lars; Wennberg, Patrik; Wester, Per; Norberg, Margareta
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏